| Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type L de Padua Silva, PA Patah, RM Saliba, NA Szewczyk, L Gilman, ... Haematologica 95 (7), 1183, 2010 | 200 | 2010 |
| Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease S Parmar, M Del Lima, Y Zou, PA Patah, P Liu, P Cano, G Rondon, ... Blood, The Journal of the American Society of Hematology 114 (14), 2884-2887, 2009 | 104 | 2009 |
| Safety, tolerability, and potential clinical activity of a glucocorticoid-induced TNF receptor–related protein agonist alone or in combination with nivolumab for patients with … KM Heinhuis, M Carlino, M Joerger, M Di Nicola, T Meniawy, S Rottey, ... JAMA oncology 6 (1), 100-107, 2020 | 85 | 2020 |
| Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies CA Ramos, RM Saliba, L De Pádua, O Khorshid, EJ Shpall, S Giralt, ... haematologica 94 (2), 249, 2009 | 65 | 2009 |
| Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias … M De Lima, RE Champlin, PF Thall, X Wang, TG Martin, JD Cook, ... Leukemia 22 (2), 258-264, 2008 | 59 | 2008 |
| Microbial contamination of hematopoietic progenitor cell products: clinical outcome PA Patah, S Parmar, J McMannis, T Sadeghi, S Karandish, G Rondon, ... Bone marrow transplantation 40 (4), 365-368, 2007 | 54 | 2007 |
| Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem … E Gurkan, PA Patah, RM Saliba, CA Ramos, BS Anderson, R Champlin, ... Bone marrow transplantation 40 (5), 461-464, 2007 | 35 | 2007 |
| Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte … SO Ciurea, RM Saliba, G Rondon, PA Patah, F Aung, P Cano, ... Biology of Blood and Marrow Transplantation 17 (6), 923-929, 2011 | 27 | 2011 |
| Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation CA Ramos, RM Saliba, L de Pádua Silva, O Khorshid, EJ Shpall, S Giralt, ... Biology of Blood and Marrow Transplantation 16 (5), 686-694, 2010 | 27 | 2010 |
| Immune‐mediated pancytopenia induced by oxaliplatin: a case report R Fontão‐Wendel, PM Hoff, A Lazar, D Freitas, Y Novis, P Patah, ... Transfusion 50 (7), 1453-1459, 2010 | 23 | 2010 |
| Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation JA de Souza, RM Saliba, P Patah, G Rondon, R Ribeiro, L de Padua Silva, ... Biology of Blood and Marrow Transplantation 15 (9), 1094-1099, 2009 | 14 | 2009 |
| Clinical activity of CC-99282, a novel, oral small molecule cereblon E3 ligase modulator (CELMoD) agent, in patients (Pts) with relapsed or refractory non-Hodgkin lymphoma (R/R … JM Michot, JC Chavez, C Carpio, S Ferrari, TA Feldman, D Morillo, ... Blood 138, 3574, 2021 | 13 | 2021 |
| Leukemia burden delays lymphocyte and platelet recovery after allo-SCT for AML RM Saliba, KV Komanduri, S Giralt, J De Souza, P Patah, B Oran, ... Bone marrow transplantation 43 (9), 685-692, 2009 | 10 | 2009 |
| Randomized Study of Double Cord Blood Transplantation (CBT) with Versus without Ex-Vivo Expansion (EXP). M de Lima, J McMannis, K Komanduri, L Worth, S Karandish, R Jones, ... Blood, The Journal of the American Society of Hematology 110 (11), 2014-2014, 2007 | 7 | 2007 |
| The role of transplantation in diffuse large B-cell lymphoma: the impact of rituximab plus chemotherapy in first-line and relapsed settings CA Rodrigues, PA Patah, YAS Novis, C Hosing, M De Lima Current hematologic malignancy reports 6, 47-57, 2011 | 6 | 2011 |
| Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors R Wang, V Baxi, Z Li, D Locke, C Hedvat, Y Sun, AM Walsh, X Shao, ... ESMO open 8 (2), 100784, 2023 | 5 | 2023 |
| S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL)–RESULTS FROM A … JM Michot, JC Chavez, C Carpio, S Ferrari, TA Feldman, D Morillo, ... HemaSphere 6, 117-118, 2022 | 3 | 2022 |
| Phase 1b trial of cereblon-modulating agents iberdomide and CC-99282 plus R-CHOP in previously untreated aggressive B-cell lymphoma J Westin, A Martín García-Sancho, M Hoffmann, TP Vassilakopoulos, ... Blood 140 (Supplement 1), 9475-9477, 2022 | 2 | 2022 |
| Methods of treating cancer with antibodies against tim3 XM Schebye, MJ Selby, MM Han, BEE Christine, A Chuntharapai, ... | 2 | 2019 |
| Pandemic influenza A H1N1/09 virus infection in hematopoietic SCT recipient DA Bastos, CA Rodrigues, P Patah, EG Kallas, V Rocha, Y Novis Bone marrow transplantation 46 (3), 467-468, 2011 | 2 | 2011 |
